免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

HiCardi+ H100

K 號:K232670 · 2024-09-20

決定日期2024-09-20
產品代碼DSH
諮詢委員會履歷
決定相當於

器材摘要

HiCardi+ H100 is the device name listed in this FDA 510(k) record. The listed applicant is MEZOO Co., Ltd.. It received FDA 510(k) clearance on 2024-09-20 under 510(k) number K232670. The device is classified under product code DSH. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the HiCardi+ H100?

HiCardi+ H100 is a medical device that received FDA 510(k) clearance on 2024-09-20. The listed applicant is MEZOO Co., Ltd.. The 510(k) number is K232670.

When did HiCardi+ H100 receive FDA 510(k) clearance?

HiCardi+ H100 received FDA 510(k) clearance on 2024-09-20, under 510(k) number K232670.

Who is the listed applicant for HiCardi+ H100?

The FDA 510(k) record lists MEZOO Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HiCardi+ H100?

The FDA product code for HiCardi+ H100 is DSH.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:DSH)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑